Brokers Set Expectations for C4 Therapeutics Q2 Earnings
C4 Therapeutics, Inc. (NASDAQ:CCCC – Free Report) – Equities research analysts at Brookline Capital Management issued their Q2 2025 EPS estimates for shares of C4 Therapeutics in a report issued on Thursday, February 27th. Brookline Capital Management analyst L. Cann expects that the company will post earnings per share of ($0.39) for the quarter. The […]
C4 Therapeutics, Inc. (NASDAQ:CCCC – Free Report) – Equities research analysts at Brookline Capital Management issued their Q2 2025 EPS estimates for shares of C4 Therapeutics in a report issued on Thursday, February 27th. Brookline Capital Management analyst L. Cann expects that the company will post earnings per share of ($0.39) for the quarter. The […]
